SynthesisArchives of osteoporosis2023

The clinical effectiveness of denosumab (Prolia®) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis.

Konstance Nicolopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.